Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( SNDS )
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Astrid Coste und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Non-Communicable Diseases Epidemiology, LSHTM, London, UK. Hauptthemen laut MEDLINE: Databases, Factual, Adverse Drug Reaction Reporting Systems, Anti-Bacterial Agents, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline.
Abstract (Originalsprache)
Background
The self controlled case series (SCCS) is one of the most promising methods for drug safety signal detection using real world data (RWD), and incorporating active comparators could potentially improve its performance by addressing time‐varying confounding by indication. The ‘Système National des Données de Santé’ (SNDS) is a large nationwide administrative claims database, which has not been used extensively for drug safety signal detection. While comparable in size to other RWD sources, it is unclear to what extent the performance of SCCS correlates with that in other sources.
Objectives
This study aims to evaluate the performance of the SCCS with and without active comparators for signal detection in the French administrative healthcare database SNDS.
Methods
We applied the SCCS to macrolide and fluoroquinolone antibiotics, using amoxicillin as the active comparator. Amoxicillin was chosen as an active comparator with similar indications. In total, 7 drugs and 30 outcomes from all organ classes were selected. We developed a reference set of 104 positive controls and 58 negative controls, using a taxonomy framework to ensure the selected drug outcome pairs are theoretically well suited to the SCCS design. The observation period lasted 2 years, with a 30‐day risk window after each dispensing. Diagnostic performance was measured using sensitivity and specificity with respect to the product labels.
Results
The sensitivity and specificity of the SCCS without active comparator were 0.89 and 0.43, respectively, when limited to pairs with satisfactory power. Specificity increased up to 0.91 with active comparators; however, sensitivity decreased to 0.52.
Conclusions
The SNDS is a useful data source for signal detection, particularly for outcomes captured in hospitals. Using a carefully designed reference set of drug‐outcome pairs well suited to the study design, the SCCS achieved satisfactory performance for signal detection in this database. In this study, the use of active comparators improved overall performance at the expense of greatly reduced sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Non-Communicable Diseases Epidemiology, LSHTM, London, UK.
- GSK, Wavre, Belgium.
ORCID-Profile: Astrid Coste, Angel Y S Wong, Andrew Bate
Förderung
- GlaxoSmithKline
Zitieren
APA
Coste, A., Wong, A. Y. S., Haguinet, F., Bate, A., & Douglas, I. J. (2025). Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( SNDS ). Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70224
Vancouver
Coste A, Wong AYS, Haguinet F, Bate A, Douglas IJ. Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( SNDS ). Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70224
BibTeX
@article{Coste2025,
author = {Coste, Astrid and Wong, Angel Y S and Haguinet, François and Bate, Andrew and Douglas, Ian J},
title = {Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database ( SNDS )},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70224}
}
EUVIMED